Casey Woodring
Stock Analyst at JP Morgan
(0.29)
# 4,087
Out of 4,829 analysts
33
Total ratings
15%
Success rate
-22.22%
Average return
Main Sectors:
Stocks Rated by Casey Woodring
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ICLR ICON Public Limited Company | Downgrades: Neutral | $265 → $150 | $139.94 | +7.19% | 6 | Apr 29, 2025 | |
| QDEL QuidelOrtho | Maintains: Underweight | $38 → $25 | $37.41 | -33.17% | 4 | Apr 21, 2025 | |
| CRL Charles River Laboratories International | Maintains: Neutral | $175 → $165 | $143.08 | +15.32% | 7 | Feb 20, 2025 | |
| HOLX Hologic | Maintains: Overweight | $92 → $94 | $58.81 | +59.84% | 5 | Nov 5, 2024 | |
| QGEN Qiagen | Maintains: Overweight | $54 → $56 | $42.94 | +29.54% | 4 | Jun 18, 2024 | |
| OSUR OraSure Technologies | Maintains: Neutral | $7 → $6 | $2.68 | +124.30% | 3 | May 13, 2024 | |
| EGBN Eagle Bancorp | Maintains: Neutral | $25 → $23 | $19.25 | +19.48% | 2 | Oct 31, 2023 | |
| SHC Sotera Health Company | Upgrades: Neutral | $6 → $18 | $13.50 | +33.38% | 2 | Jan 23, 2023 |
ICON Public Limited Company
Apr 29, 2025
Downgrades: Neutral
Price Target: $265 → $150
Current: $139.94
Upside: +7.19%
QuidelOrtho
Apr 21, 2025
Maintains: Underweight
Price Target: $38 → $25
Current: $37.41
Upside: -33.17%
Charles River Laboratories International
Feb 20, 2025
Maintains: Neutral
Price Target: $175 → $165
Current: $143.08
Upside: +15.32%
Hologic
Nov 5, 2024
Maintains: Overweight
Price Target: $92 → $94
Current: $58.81
Upside: +59.84%
Qiagen
Jun 18, 2024
Maintains: Overweight
Price Target: $54 → $56
Current: $42.94
Upside: +29.54%
OraSure Technologies
May 13, 2024
Maintains: Neutral
Price Target: $7 → $6
Current: $2.68
Upside: +124.30%
Eagle Bancorp
Oct 31, 2023
Maintains: Neutral
Price Target: $25 → $23
Current: $19.25
Upside: +19.48%
Sotera Health Company
Jan 23, 2023
Upgrades: Neutral
Price Target: $6 → $18
Current: $13.50
Upside: +33.38%